Heartcore Enterprises, Inc. - Form 8-K Summary
Business Context and Reporting Period
Heartcore Enterprises, Inc. (HTCR), a Delaware corporation and emerging growth company, filed this Current Report on Form 8-K on May 30, 2025. The filing discloses the entry into a material definitive agreement with tmsuk Co. Ltd., a Japanese corporation, effective as of May 30, 2025.
Key Financial Metrics and Transaction Terms
This filing does not report the Company's consolidated revenue, profit, cash flow, or debt levels. The financial impact is limited to the terms of the new consulting agreement:
- Compensation: tmsuk agreed to pay Heartcore $500,000 in cash over a nine-month term.
- Payment Schedule: $200,000 on the effective date (May 30, 2025), $150,000 on the three-month anniversary, and $150,000 on the six-month anniversary.
- Equity Component: tmsuk agreed to issue a warrant to Heartcore for 3% of tmsuk's fully diluted share capital, subject to stockholder approval.
- Extension Rate: If the agreement extends beyond nine months, services will be billed at $150 per hour.
Material Changes and Agreement Scope
The primary material change is the execution of the "tmsuk Consulting Agreement." Heartcore will provide services to assist tmsuk with a potential initial public offering (IPO) or de-SPAC transaction. Services include:
- Assisting in the selection of legal, underwriting, and auditing firms.
- Preparing documentation for internal controls and S-1 or F-1 filings.
- Converting accounting data from Japanese standards to U.S. GAAP.
- Creating English web pages and investor presentations.
The agreement explicitly states that Heartcore will not provide legal advice, perform accounting services, act as an investment advisor, or handle funds/securities for tmsuk.
Guidance, Risks, and Contingencies
The filing contains no forward-looking financial guidance for Heartcore's own operations. Key contingencies and risks associated with the agreement include:
- Stockholder Approval: The issuance of the 3% warrant is contingent upon approval by tmsuk's stockholders.
- Alternative Compensation: If stockholder approval is not obtained within 90 days, the parties must agree on an alternate method to provide equivalent value to the warrant.
- Termination: Either party may terminate the agreement at any time upon notice.
Investor Verification Checklist
- Verify the receipt of the initial $200,000 payment in Heartcore's next financial report.
- Monitor tmsuk's corporate actions to confirm if stockholder approval for the warrant issuance is obtained within 90 days.
- Review the full text of the Consulting and Services Agreement (Exhibit 10.1) for specific termination clauses and adjustment mechanisms for the warrant.
- Confirm whether the services provided will be classified as revenue under U.S. GAAP in the period they are performed.